Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 18 (1) , e20-e38
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer CellsPLOS ONE, 2013
- Clinical impact of programmed cell death ligand 1 expression in colorectal cancerEuropean Journal of Cancer, 2013
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell CarcinomaCancer Research, 2013
- Targeting PD-1/PD-L1 interactions for cancer immunotherapyOncoImmunology, 2012
- B7-H1 Expressed by Activated CD8 T Cells Is Essential for Their SurvivalThe Journal of Immunology, 2011
- Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08Journal of Clinical Oncology, 2011
- B7-H1 (Programmed Cell Death Ligand 1) Is Required for the Development of Multifunctional Th1 Cells and Immunity to Primary, but Not Secondary, Salmonella InfectionThe Journal of Immunology, 2010
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular CarcinomaClinical Cancer Research, 2009
- T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with SurvivalClinical Cancer Research, 2008
- Inhibitory B7-family molecules in the tumour microenvironmentNature Reviews Immunology, 2008